SHARES PLUMMETS AFTER NOVO NORDISK DEAL FAILURE

Shares of HIMS experienced a dramatic slump today following the unexpected cancellation of its agreement with pharmaceutical giant Novo Nordisk. Investors responded negatively to the news, sending its stock price plummeting by more than 10%. The reason for the dissolution of the partnership remains unclear, but industry analysts speculate that it c